nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—ABCB1—lung cancer	0.18	1	CbGaD
Propafenone—ABCB1—Topotecan—lung cancer	0.0248	0.0495	CbGbCtD
Propafenone—CYP2C9—Gefitinib—lung cancer	0.0233	0.0466	CbGbCtD
Propafenone—ABCB1—Gefitinib—lung cancer	0.0227	0.0452	CbGbCtD
Propafenone—CYP2C9—Teniposide—lung cancer	0.0226	0.0452	CbGbCtD
Propafenone—CYP2D6—Gefitinib—lung cancer	0.0213	0.0426	CbGbCtD
Propafenone—CYP2C8—Erlotinib—lung cancer	0.0198	0.0395	CbGbCtD
Propafenone—CYP2C8—Paclitaxel—lung cancer	0.0181	0.0362	CbGbCtD
Propafenone—ABCB1—Vinorelbine—lung cancer	0.0175	0.0348	CbGbCtD
Propafenone—CYP2D6—Vinorelbine—lung cancer	0.0164	0.0328	CbGbCtD
Propafenone—CYP1A2—Erlotinib—lung cancer	0.0153	0.0306	CbGbCtD
Propafenone—CYP3A4—Topotecan—lung cancer	0.0148	0.0296	CbGbCtD
Propafenone—CYP2C8—Etoposide—lung cancer	0.0143	0.0286	CbGbCtD
Propafenone—ABCB1—Crizotinib—lung cancer	0.0139	0.0277	CbGbCtD
Propafenone—CYP3A4—Gefitinib—lung cancer	0.0136	0.0271	CbGbCtD
Propafenone—ABCB1—Gemcitabine—lung cancer	0.0136	0.0271	CbGbCtD
Propafenone—ABCB1—Erlotinib—lung cancer	0.0134	0.0267	CbGbCtD
Propafenone—CYP3A4—Teniposide—lung cancer	0.0132	0.0263	CbGbCtD
Propafenone—CYP2C9—Paclitaxel—lung cancer	0.0126	0.0252	CbGbCtD
Propafenone—CYP2D6—Erlotinib—lung cancer	0.0126	0.0252	CbGbCtD
Propafenone—ABCB1—Paclitaxel—lung cancer	0.0123	0.0245	CbGbCtD
Propafenone—ABCB1—Irinotecan—lung cancer	0.0121	0.0241	CbGbCtD
Propafenone—CYP1A2—Etoposide—lung cancer	0.0111	0.0221	CbGbCtD
Propafenone—ABCB1—Vinblastine—lung cancer	0.0108	0.0215	CbGbCtD
Propafenone—CYP3A4—Vinorelbine—lung cancer	0.0105	0.0209	CbGbCtD
Propafenone—CYP2C9—Cisplatin—lung cancer	0.0102	0.0203	CbGbCtD
Propafenone—CYP2D6—Vinblastine—lung cancer	0.0101	0.0202	CbGbCtD
Propafenone—ABCB1—Cisplatin—lung cancer	0.00986	0.0197	CbGbCtD
Propafenone—ABCB1—Etoposide—lung cancer	0.00969	0.0193	CbGbCtD
Propafenone—ABCB1—Docetaxel—lung cancer	0.00887	0.0177	CbGbCtD
Propafenone—CYP3A4—Crizotinib—lung cancer	0.00832	0.0166	CbGbCtD
Propafenone—CYP3A4—Erlotinib—lung cancer	0.00803	0.016	CbGbCtD
Propafenone—CYP3A4—Paclitaxel—lung cancer	0.00735	0.0147	CbGbCtD
Propafenone—CYP3A4—Irinotecan—lung cancer	0.00725	0.0145	CbGbCtD
Propafenone—ABCB1—Doxorubicin—lung cancer	0.00661	0.0132	CbGbCtD
Propafenone—CYP3A4—Vinblastine—lung cancer	0.00644	0.0129	CbGbCtD
Propafenone—ABCB1—Methotrexate—lung cancer	0.0064	0.0128	CbGbCtD
Propafenone—CYP2D6—Doxorubicin—lung cancer	0.00623	0.0124	CbGbCtD
Propafenone—CYP3A4—Etoposide—lung cancer	0.00581	0.0116	CbGbCtD
Propafenone—CYP3A4—Docetaxel—lung cancer	0.00531	0.0106	CbGbCtD
Propafenone—CYP3A4—Doxorubicin—lung cancer	0.00396	0.0079	CbGbCtD
Propafenone—Carvedilol—HIF1A—lung cancer	0.00104	0.314	CrCbGaD
Propafenone—Carvedilol—VEGFA—lung cancer	0.000419	0.127	CrCbGaD
Propafenone—Mirabegron—ALB—lung cancer	0.00028	0.0846	CrCbGaD
Propafenone—Mirabegron—ABCB1—lung cancer	0.000267	0.0808	CrCbGaD
Propafenone—Oxaprozin—PTGS2—lung cancer	0.000227	0.0687	CrCbGaD
Propafenone—Salsalate—PTGS2—lung cancer	0.000227	0.0687	CrCbGaD
Propafenone—Carvedilol—CYP2E1—lung cancer	0.000205	0.062	CrCbGaD
Propafenone—Carvedilol—CYP1A1—lung cancer	0.000202	0.0611	CrCbGaD
Propafenone—Propranolol—CYP1A1—lung cancer	0.000154	0.0465	CrCbGaD
Propafenone—Carvedilol—ABCB1—lung cancer	0.000108	0.0325	CrCbGaD
Propafenone—Fentanyl—ABCB1—lung cancer	9.79e-05	0.0296	CrCbGaD
Propafenone—Propranolol—ABCB1—lung cancer	8.18e-05	0.0247	CrCbGaD
Propafenone—Haemoglobin—Methotrexate—lung cancer	6.13e-05	0.000266	CcSEcCtD
Propafenone—Gastrointestinal disorder—Paclitaxel—lung cancer	6.13e-05	0.000265	CcSEcCtD
Propafenone—Fatigue—Paclitaxel—lung cancer	6.12e-05	0.000265	CcSEcCtD
Propafenone—Haemorrhage—Methotrexate—lung cancer	6.1e-05	0.000264	CcSEcCtD
Propafenone—Hepatitis—Methotrexate—lung cancer	6.1e-05	0.000264	CcSEcCtD
Propafenone—Pollakiuria—Doxorubicin—lung cancer	6.1e-05	0.000264	CcSEcCtD
Propafenone—Asthenia—Gemcitabine—lung cancer	6.08e-05	0.000263	CcSEcCtD
Propafenone—Pain—Paclitaxel—lung cancer	6.07e-05	0.000263	CcSEcCtD
Propafenone—Constipation—Paclitaxel—lung cancer	6.07e-05	0.000263	CcSEcCtD
Propafenone—Confusional state—Docetaxel—lung cancer	6.06e-05	0.000263	CcSEcCtD
Propafenone—Urinary tract disorder—Methotrexate—lung cancer	6.02e-05	0.000261	CcSEcCtD
Propafenone—Oedema—Docetaxel—lung cancer	6.01e-05	0.00026	CcSEcCtD
Propafenone—Weight increased—Doxorubicin—lung cancer	6.01e-05	0.00026	CcSEcCtD
Propafenone—Pruritus—Gemcitabine—lung cancer	6e-05	0.00026	CcSEcCtD
Propafenone—Urethral disorder—Methotrexate—lung cancer	5.98e-05	0.000259	CcSEcCtD
Propafenone—Infection—Docetaxel—lung cancer	5.97e-05	0.000259	CcSEcCtD
Propafenone—Weight decreased—Doxorubicin—lung cancer	5.97e-05	0.000259	CcSEcCtD
Propafenone—Feeling abnormal—Etoposide—lung cancer	5.96e-05	0.000258	CcSEcCtD
Propafenone—Hyperglycaemia—Doxorubicin—lung cancer	5.95e-05	0.000258	CcSEcCtD
Propafenone—Diarrhoea—Irinotecan—lung cancer	5.95e-05	0.000258	CcSEcCtD
Propafenone—Gastrointestinal pain—Etoposide—lung cancer	5.92e-05	0.000256	CcSEcCtD
Propafenone—Shock—Docetaxel—lung cancer	5.92e-05	0.000256	CcSEcCtD
Propafenone—Nervous system disorder—Docetaxel—lung cancer	5.9e-05	0.000255	CcSEcCtD
Propafenone—Thrombocytopenia—Docetaxel—lung cancer	5.89e-05	0.000255	CcSEcCtD
Propafenone—Infestation NOS—Doxorubicin—lung cancer	5.88e-05	0.000255	CcSEcCtD
Propafenone—Drowsiness—Doxorubicin—lung cancer	5.88e-05	0.000255	CcSEcCtD
Propafenone—Infestation—Doxorubicin—lung cancer	5.88e-05	0.000255	CcSEcCtD
Propafenone—Visual impairment—Methotrexate—lung cancer	5.88e-05	0.000255	CcSEcCtD
Propafenone—Tachycardia—Docetaxel—lung cancer	5.87e-05	0.000254	CcSEcCtD
Propafenone—Feeling abnormal—Paclitaxel—lung cancer	5.85e-05	0.000253	CcSEcCtD
Propafenone—Skin disorder—Docetaxel—lung cancer	5.84e-05	0.000253	CcSEcCtD
Propafenone—Hypersensitivity—Cisplatin—lung cancer	5.82e-05	0.000252	CcSEcCtD
Propafenone—Gastrointestinal pain—Paclitaxel—lung cancer	5.8e-05	0.000251	CcSEcCtD
Propafenone—Diarrhoea—Gemcitabine—lung cancer	5.8e-05	0.000251	CcSEcCtD
Propafenone—Renal failure—Doxorubicin—lung cancer	5.78e-05	0.000251	CcSEcCtD
Propafenone—Neuropathy peripheral—Doxorubicin—lung cancer	5.77e-05	0.00025	CcSEcCtD
Propafenone—Dizziness—Irinotecan—lung cancer	5.75e-05	0.000249	CcSEcCtD
Propafenone—Urticaria—Etoposide—lung cancer	5.75e-05	0.000249	CcSEcCtD
Propafenone—Jaundice—Doxorubicin—lung cancer	5.74e-05	0.000248	CcSEcCtD
Propafenone—Stomatitis—Doxorubicin—lung cancer	5.74e-05	0.000248	CcSEcCtD
Propafenone—Anorexia—Docetaxel—lung cancer	5.73e-05	0.000248	CcSEcCtD
Propafenone—Abdominal pain—Etoposide—lung cancer	5.72e-05	0.000248	CcSEcCtD
Propafenone—Body temperature increased—Etoposide—lung cancer	5.72e-05	0.000248	CcSEcCtD
Propafenone—Eye disorder—Methotrexate—lung cancer	5.7e-05	0.000247	CcSEcCtD
Propafenone—Tinnitus—Methotrexate—lung cancer	5.69e-05	0.000246	CcSEcCtD
Propafenone—Asthenia—Cisplatin—lung cancer	5.67e-05	0.000245	CcSEcCtD
Propafenone—Cardiac disorder—Methotrexate—lung cancer	5.66e-05	0.000245	CcSEcCtD
Propafenone—Urticaria—Paclitaxel—lung cancer	5.64e-05	0.000244	CcSEcCtD
Propafenone—Hypotension—Docetaxel—lung cancer	5.62e-05	0.000243	CcSEcCtD
Propafenone—Haematuria—Doxorubicin—lung cancer	5.61e-05	0.000243	CcSEcCtD
Propafenone—Abdominal pain—Paclitaxel—lung cancer	5.61e-05	0.000243	CcSEcCtD
Propafenone—Body temperature increased—Paclitaxel—lung cancer	5.61e-05	0.000243	CcSEcCtD
Propafenone—Hepatobiliary disease—Doxorubicin—lung cancer	5.57e-05	0.000241	CcSEcCtD
Propafenone—Epistaxis—Doxorubicin—lung cancer	5.55e-05	0.00024	CcSEcCtD
Propafenone—Angiopathy—Methotrexate—lung cancer	5.53e-05	0.00024	CcSEcCtD
Propafenone—Vomiting—Irinotecan—lung cancer	5.53e-05	0.00024	CcSEcCtD
Propafenone—Immune system disorder—Methotrexate—lung cancer	5.51e-05	0.000239	CcSEcCtD
Propafenone—Mediastinal disorder—Methotrexate—lung cancer	5.5e-05	0.000238	CcSEcCtD
Propafenone—Agranulocytosis—Doxorubicin—lung cancer	5.49e-05	0.000238	CcSEcCtD
Propafenone—Rash—Irinotecan—lung cancer	5.48e-05	0.000238	CcSEcCtD
Propafenone—Dermatitis—Irinotecan—lung cancer	5.48e-05	0.000237	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Docetaxel—lung cancer	5.48e-05	0.000237	CcSEcCtD
Propafenone—Headache—Irinotecan—lung cancer	5.45e-05	0.000236	CcSEcCtD
Propafenone—Insomnia—Docetaxel—lung cancer	5.44e-05	0.000236	CcSEcCtD
Propafenone—Diarrhoea—Cisplatin—lung cancer	5.4e-05	0.000234	CcSEcCtD
Propafenone—Paraesthesia—Docetaxel—lung cancer	5.4e-05	0.000234	CcSEcCtD
Propafenone—Alopecia—Methotrexate—lung cancer	5.39e-05	0.000233	CcSEcCtD
Propafenone—Vomiting—Gemcitabine—lung cancer	5.39e-05	0.000233	CcSEcCtD
Propafenone—Bradycardia—Doxorubicin—lung cancer	5.38e-05	0.000233	CcSEcCtD
Propafenone—Dyspnoea—Docetaxel—lung cancer	5.36e-05	0.000232	CcSEcCtD
Propafenone—Somnolence—Docetaxel—lung cancer	5.35e-05	0.000232	CcSEcCtD
Propafenone—Mental disorder—Methotrexate—lung cancer	5.34e-05	0.000231	CcSEcCtD
Propafenone—Rash—Gemcitabine—lung cancer	5.34e-05	0.000231	CcSEcCtD
Propafenone—Dermatitis—Gemcitabine—lung cancer	5.34e-05	0.000231	CcSEcCtD
Propafenone—Hypersensitivity—Etoposide—lung cancer	5.33e-05	0.000231	CcSEcCtD
Propafenone—Erythema—Methotrexate—lung cancer	5.31e-05	0.00023	CcSEcCtD
Propafenone—Malnutrition—Methotrexate—lung cancer	5.31e-05	0.00023	CcSEcCtD
Propafenone—Haemoglobin—Doxorubicin—lung cancer	5.31e-05	0.00023	CcSEcCtD
Propafenone—Headache—Gemcitabine—lung cancer	5.31e-05	0.00023	CcSEcCtD
Propafenone—Rhinitis—Doxorubicin—lung cancer	5.3e-05	0.000229	CcSEcCtD
Propafenone—Dyspepsia—Docetaxel—lung cancer	5.29e-05	0.000229	CcSEcCtD
Propafenone—Haemorrhage—Doxorubicin—lung cancer	5.28e-05	0.000229	CcSEcCtD
Propafenone—Hepatitis—Doxorubicin—lung cancer	5.28e-05	0.000229	CcSEcCtD
Propafenone—Hypoaesthesia—Doxorubicin—lung cancer	5.26e-05	0.000228	CcSEcCtD
Propafenone—Decreased appetite—Docetaxel—lung cancer	5.23e-05	0.000226	CcSEcCtD
Propafenone—Hypersensitivity—Paclitaxel—lung cancer	5.23e-05	0.000226	CcSEcCtD
Propafenone—Urinary tract disorder—Doxorubicin—lung cancer	5.22e-05	0.000226	CcSEcCtD
Propafenone—Dysgeusia—Methotrexate—lung cancer	5.2e-05	0.000225	CcSEcCtD
Propafenone—Gastrointestinal disorder—Docetaxel—lung cancer	5.19e-05	0.000225	CcSEcCtD
Propafenone—Asthenia—Etoposide—lung cancer	5.19e-05	0.000225	CcSEcCtD
Propafenone—Connective tissue disorder—Doxorubicin—lung cancer	5.19e-05	0.000225	CcSEcCtD
Propafenone—Fatigue—Docetaxel—lung cancer	5.18e-05	0.000225	CcSEcCtD
Propafenone—Urethral disorder—Doxorubicin—lung cancer	5.18e-05	0.000224	CcSEcCtD
Propafenone—Nausea—Irinotecan—lung cancer	5.17e-05	0.000224	CcSEcCtD
Propafenone—Pain—Docetaxel—lung cancer	5.14e-05	0.000223	CcSEcCtD
Propafenone—Constipation—Docetaxel—lung cancer	5.14e-05	0.000223	CcSEcCtD
Propafenone—Pruritus—Etoposide—lung cancer	5.12e-05	0.000222	CcSEcCtD
Propafenone—Visual impairment—Doxorubicin—lung cancer	5.09e-05	0.00022	CcSEcCtD
Propafenone—Asthenia—Paclitaxel—lung cancer	5.09e-05	0.00022	CcSEcCtD
Propafenone—Nausea—Gemcitabine—lung cancer	5.03e-05	0.000218	CcSEcCtD
Propafenone—Vomiting—Cisplatin—lung cancer	5.02e-05	0.000217	CcSEcCtD
Propafenone—Pruritus—Paclitaxel—lung cancer	5.02e-05	0.000217	CcSEcCtD
Propafenone—Vision blurred—Methotrexate—lung cancer	5e-05	0.000217	CcSEcCtD
Propafenone—Rash—Cisplatin—lung cancer	4.98e-05	0.000216	CcSEcCtD
Propafenone—Dermatitis—Cisplatin—lung cancer	4.98e-05	0.000215	CcSEcCtD
Propafenone—Feeling abnormal—Docetaxel—lung cancer	4.96e-05	0.000215	CcSEcCtD
Propafenone—Diarrhoea—Etoposide—lung cancer	4.95e-05	0.000214	CcSEcCtD
Propafenone—Eye disorder—Doxorubicin—lung cancer	4.94e-05	0.000214	CcSEcCtD
Propafenone—Ill-defined disorder—Methotrexate—lung cancer	4.93e-05	0.000213	CcSEcCtD
Propafenone—Tinnitus—Doxorubicin—lung cancer	4.93e-05	0.000213	CcSEcCtD
Propafenone—Gastrointestinal pain—Docetaxel—lung cancer	4.92e-05	0.000213	CcSEcCtD
Propafenone—Anaemia—Methotrexate—lung cancer	4.91e-05	0.000213	CcSEcCtD
Propafenone—Cardiac disorder—Doxorubicin—lung cancer	4.9e-05	0.000212	CcSEcCtD
Propafenone—Flushing—Doxorubicin—lung cancer	4.9e-05	0.000212	CcSEcCtD
Propafenone—Diarrhoea—Paclitaxel—lung cancer	4.85e-05	0.00021	CcSEcCtD
Propafenone—Angiopathy—Doxorubicin—lung cancer	4.79e-05	0.000208	CcSEcCtD
Propafenone—Malaise—Methotrexate—lung cancer	4.79e-05	0.000207	CcSEcCtD
Propafenone—Dizziness—Etoposide—lung cancer	4.78e-05	0.000207	CcSEcCtD
Propafenone—Immune system disorder—Doxorubicin—lung cancer	4.77e-05	0.000207	CcSEcCtD
Propafenone—Vertigo—Methotrexate—lung cancer	4.77e-05	0.000207	CcSEcCtD
Propafenone—Mediastinal disorder—Doxorubicin—lung cancer	4.76e-05	0.000206	CcSEcCtD
Propafenone—Abdominal pain—Docetaxel—lung cancer	4.75e-05	0.000206	CcSEcCtD
Propafenone—Body temperature increased—Docetaxel—lung cancer	4.75e-05	0.000206	CcSEcCtD
Propafenone—Leukopenia—Methotrexate—lung cancer	4.75e-05	0.000206	CcSEcCtD
Propafenone—Arrhythmia—Doxorubicin—lung cancer	4.72e-05	0.000204	CcSEcCtD
Propafenone—Dizziness—Paclitaxel—lung cancer	4.69e-05	0.000203	CcSEcCtD
Propafenone—Nausea—Cisplatin—lung cancer	4.69e-05	0.000203	CcSEcCtD
Propafenone—Alopecia—Doxorubicin—lung cancer	4.67e-05	0.000202	CcSEcCtD
Propafenone—Cough—Methotrexate—lung cancer	4.63e-05	0.000201	CcSEcCtD
Propafenone—Mental disorder—Doxorubicin—lung cancer	4.63e-05	0.0002	CcSEcCtD
Propafenone—Convulsion—Methotrexate—lung cancer	4.6e-05	0.000199	CcSEcCtD
Propafenone—Vomiting—Etoposide—lung cancer	4.6e-05	0.000199	CcSEcCtD
Propafenone—Malnutrition—Doxorubicin—lung cancer	4.6e-05	0.000199	CcSEcCtD
Propafenone—Erythema—Doxorubicin—lung cancer	4.6e-05	0.000199	CcSEcCtD
Propafenone—Rash—Etoposide—lung cancer	4.56e-05	0.000198	CcSEcCtD
Propafenone—Dermatitis—Etoposide—lung cancer	4.56e-05	0.000197	CcSEcCtD
Propafenone—Headache—Etoposide—lung cancer	4.53e-05	0.000196	CcSEcCtD
Propafenone—Flatulence—Doxorubicin—lung cancer	4.53e-05	0.000196	CcSEcCtD
Propafenone—Chest pain—Methotrexate—lung cancer	4.52e-05	0.000196	CcSEcCtD
Propafenone—Myalgia—Methotrexate—lung cancer	4.52e-05	0.000196	CcSEcCtD
Propafenone—Tension—Doxorubicin—lung cancer	4.51e-05	0.000195	CcSEcCtD
Propafenone—Vomiting—Paclitaxel—lung cancer	4.51e-05	0.000195	CcSEcCtD
Propafenone—Dysgeusia—Doxorubicin—lung cancer	4.5e-05	0.000195	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	4.49e-05	0.000194	CcSEcCtD
Propafenone—Rash—Paclitaxel—lung cancer	4.47e-05	0.000194	CcSEcCtD
Propafenone—Dermatitis—Paclitaxel—lung cancer	4.47e-05	0.000194	CcSEcCtD
Propafenone—Discomfort—Methotrexate—lung cancer	4.47e-05	0.000193	CcSEcCtD
Propafenone—Nervousness—Doxorubicin—lung cancer	4.47e-05	0.000193	CcSEcCtD
Propafenone—Headache—Paclitaxel—lung cancer	4.44e-05	0.000192	CcSEcCtD
Propafenone—Hypersensitivity—Docetaxel—lung cancer	4.43e-05	0.000192	CcSEcCtD
Propafenone—Muscle spasms—Doxorubicin—lung cancer	4.42e-05	0.000191	CcSEcCtD
Propafenone—Confusional state—Methotrexate—lung cancer	4.37e-05	0.000189	CcSEcCtD
Propafenone—Vision blurred—Doxorubicin—lung cancer	4.33e-05	0.000188	CcSEcCtD
Propafenone—Asthenia—Docetaxel—lung cancer	4.31e-05	0.000187	CcSEcCtD
Propafenone—Infection—Methotrexate—lung cancer	4.31e-05	0.000186	CcSEcCtD
Propafenone—Nausea—Etoposide—lung cancer	4.3e-05	0.000186	CcSEcCtD
Propafenone—Ill-defined disorder—Doxorubicin—lung cancer	4.27e-05	0.000185	CcSEcCtD
Propafenone—Pruritus—Docetaxel—lung cancer	4.25e-05	0.000184	CcSEcCtD
Propafenone—Nervous system disorder—Methotrexate—lung cancer	4.25e-05	0.000184	CcSEcCtD
Propafenone—Anaemia—Doxorubicin—lung cancer	4.25e-05	0.000184	CcSEcCtD
Propafenone—Thrombocytopenia—Methotrexate—lung cancer	4.24e-05	0.000184	CcSEcCtD
Propafenone—Nausea—Paclitaxel—lung cancer	4.21e-05	0.000183	CcSEcCtD
Propafenone—Skin disorder—Methotrexate—lung cancer	4.21e-05	0.000182	CcSEcCtD
Propafenone—Hyperhidrosis—Methotrexate—lung cancer	4.19e-05	0.000181	CcSEcCtD
Propafenone—Malaise—Doxorubicin—lung cancer	4.15e-05	0.00018	CcSEcCtD
Propafenone—Vertigo—Doxorubicin—lung cancer	4.13e-05	0.000179	CcSEcCtD
Propafenone—Anorexia—Methotrexate—lung cancer	4.13e-05	0.000179	CcSEcCtD
Propafenone—Syncope—Doxorubicin—lung cancer	4.12e-05	0.000179	CcSEcCtD
Propafenone—Leukopenia—Doxorubicin—lung cancer	4.12e-05	0.000178	CcSEcCtD
Propafenone—Diarrhoea—Docetaxel—lung cancer	4.11e-05	0.000178	CcSEcCtD
Propafenone—Palpitations—Doxorubicin—lung cancer	4.06e-05	0.000176	CcSEcCtD
Propafenone—Hypotension—Methotrexate—lung cancer	4.05e-05	0.000175	CcSEcCtD
Propafenone—Loss of consciousness—Doxorubicin—lung cancer	4.04e-05	0.000175	CcSEcCtD
Propafenone—Cough—Doxorubicin—lung cancer	4.01e-05	0.000174	CcSEcCtD
Propafenone—Convulsion—Doxorubicin—lung cancer	3.98e-05	0.000173	CcSEcCtD
Propafenone—Dizziness—Docetaxel—lung cancer	3.98e-05	0.000172	CcSEcCtD
Propafenone—Hypertension—Doxorubicin—lung cancer	3.97e-05	0.000172	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Methotrexate—lung cancer	3.95e-05	0.000171	CcSEcCtD
Propafenone—Insomnia—Methotrexate—lung cancer	3.92e-05	0.00017	CcSEcCtD
Propafenone—Myalgia—Doxorubicin—lung cancer	3.91e-05	0.00017	CcSEcCtD
Propafenone—Chest pain—Doxorubicin—lung cancer	3.91e-05	0.00017	CcSEcCtD
Propafenone—Anxiety—Doxorubicin—lung cancer	3.9e-05	0.000169	CcSEcCtD
Propafenone—Paraesthesia—Methotrexate—lung cancer	3.89e-05	0.000169	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	3.89e-05	0.000168	CcSEcCtD
Propafenone—Discomfort—Doxorubicin—lung cancer	3.87e-05	0.000168	CcSEcCtD
Propafenone—Dyspnoea—Methotrexate—lung cancer	3.86e-05	0.000167	CcSEcCtD
Propafenone—Somnolence—Methotrexate—lung cancer	3.85e-05	0.000167	CcSEcCtD
Propafenone—Dry mouth—Doxorubicin—lung cancer	3.83e-05	0.000166	CcSEcCtD
Propafenone—Vomiting—Docetaxel—lung cancer	3.82e-05	0.000166	CcSEcCtD
Propafenone—Dyspepsia—Methotrexate—lung cancer	3.82e-05	0.000165	CcSEcCtD
Propafenone—Rash—Docetaxel—lung cancer	3.79e-05	0.000164	CcSEcCtD
Propafenone—Dermatitis—Docetaxel—lung cancer	3.79e-05	0.000164	CcSEcCtD
Propafenone—Confusional state—Doxorubicin—lung cancer	3.78e-05	0.000164	CcSEcCtD
Propafenone—Decreased appetite—Methotrexate—lung cancer	3.77e-05	0.000163	CcSEcCtD
Propafenone—Headache—Docetaxel—lung cancer	3.77e-05	0.000163	CcSEcCtD
Propafenone—Oedema—Doxorubicin—lung cancer	3.75e-05	0.000163	CcSEcCtD
Propafenone—Gastrointestinal disorder—Methotrexate—lung cancer	3.74e-05	0.000162	CcSEcCtD
Propafenone—Fatigue—Methotrexate—lung cancer	3.74e-05	0.000162	CcSEcCtD
Propafenone—Infection—Doxorubicin—lung cancer	3.73e-05	0.000161	CcSEcCtD
Propafenone—Pain—Methotrexate—lung cancer	3.71e-05	0.000161	CcSEcCtD
Propafenone—Shock—Doxorubicin—lung cancer	3.69e-05	0.00016	CcSEcCtD
Propafenone—Nervous system disorder—Doxorubicin—lung cancer	3.68e-05	0.000159	CcSEcCtD
Propafenone—Thrombocytopenia—Doxorubicin—lung cancer	3.67e-05	0.000159	CcSEcCtD
Propafenone—Tachycardia—Doxorubicin—lung cancer	3.66e-05	0.000159	CcSEcCtD
Propafenone—Skin disorder—Doxorubicin—lung cancer	3.65e-05	0.000158	CcSEcCtD
Propafenone—Hyperhidrosis—Doxorubicin—lung cancer	3.63e-05	0.000157	CcSEcCtD
Propafenone—Anorexia—Doxorubicin—lung cancer	3.58e-05	0.000155	CcSEcCtD
Propafenone—Nausea—Docetaxel—lung cancer	3.57e-05	0.000155	CcSEcCtD
Propafenone—Feeling abnormal—Methotrexate—lung cancer	3.57e-05	0.000155	CcSEcCtD
Propafenone—Gastrointestinal pain—Methotrexate—lung cancer	3.54e-05	0.000153	CcSEcCtD
Propafenone—Hypotension—Doxorubicin—lung cancer	3.51e-05	0.000152	CcSEcCtD
Propafenone—Urticaria—Methotrexate—lung cancer	3.44e-05	0.000149	CcSEcCtD
Propafenone—Abdominal pain—Methotrexate—lung cancer	3.43e-05	0.000148	CcSEcCtD
Propafenone—Body temperature increased—Methotrexate—lung cancer	3.43e-05	0.000148	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.42e-05	0.000148	CcSEcCtD
Propafenone—Insomnia—Doxorubicin—lung cancer	3.39e-05	0.000147	CcSEcCtD
Propafenone—Paraesthesia—Doxorubicin—lung cancer	3.37e-05	0.000146	CcSEcCtD
Propafenone—Dyspnoea—Doxorubicin—lung cancer	3.35e-05	0.000145	CcSEcCtD
Propafenone—Somnolence—Doxorubicin—lung cancer	3.34e-05	0.000145	CcSEcCtD
Propafenone—Dyspepsia—Doxorubicin—lung cancer	3.3e-05	0.000143	CcSEcCtD
Propafenone—Decreased appetite—Doxorubicin—lung cancer	3.26e-05	0.000141	CcSEcCtD
Propafenone—Gastrointestinal disorder—Doxorubicin—lung cancer	3.24e-05	0.00014	CcSEcCtD
Propafenone—Fatigue—Doxorubicin—lung cancer	3.24e-05	0.00014	CcSEcCtD
Propafenone—Pain—Doxorubicin—lung cancer	3.21e-05	0.000139	CcSEcCtD
Propafenone—Constipation—Doxorubicin—lung cancer	3.21e-05	0.000139	CcSEcCtD
Propafenone—Hypersensitivity—Methotrexate—lung cancer	3.19e-05	0.000138	CcSEcCtD
Propafenone—Asthenia—Methotrexate—lung cancer	3.11e-05	0.000135	CcSEcCtD
Propafenone—Feeling abnormal—Doxorubicin—lung cancer	3.09e-05	0.000134	CcSEcCtD
Propafenone—Gastrointestinal pain—Doxorubicin—lung cancer	3.07e-05	0.000133	CcSEcCtD
Propafenone—Pruritus—Methotrexate—lung cancer	3.07e-05	0.000133	CcSEcCtD
Propafenone—Urticaria—Doxorubicin—lung cancer	2.98e-05	0.000129	CcSEcCtD
Propafenone—Body temperature increased—Doxorubicin—lung cancer	2.97e-05	0.000128	CcSEcCtD
Propafenone—Abdominal pain—Doxorubicin—lung cancer	2.97e-05	0.000128	CcSEcCtD
Propafenone—Diarrhoea—Methotrexate—lung cancer	2.97e-05	0.000128	CcSEcCtD
Propafenone—Dizziness—Methotrexate—lung cancer	2.87e-05	0.000124	CcSEcCtD
Propafenone—Hypersensitivity—Doxorubicin—lung cancer	2.77e-05	0.00012	CcSEcCtD
Propafenone—Vomiting—Methotrexate—lung cancer	2.76e-05	0.000119	CcSEcCtD
Propafenone—Rash—Methotrexate—lung cancer	2.73e-05	0.000118	CcSEcCtD
Propafenone—Dermatitis—Methotrexate—lung cancer	2.73e-05	0.000118	CcSEcCtD
Propafenone—Headache—Methotrexate—lung cancer	2.72e-05	0.000118	CcSEcCtD
Propafenone—Asthenia—Doxorubicin—lung cancer	2.69e-05	0.000117	CcSEcCtD
Propafenone—Pruritus—Doxorubicin—lung cancer	2.66e-05	0.000115	CcSEcCtD
Propafenone—Nausea—Methotrexate—lung cancer	2.57e-05	0.000111	CcSEcCtD
Propafenone—Diarrhoea—Doxorubicin—lung cancer	2.57e-05	0.000111	CcSEcCtD
Propafenone—Dizziness—Doxorubicin—lung cancer	2.48e-05	0.000107	CcSEcCtD
Propafenone—Vomiting—Doxorubicin—lung cancer	2.39e-05	0.000103	CcSEcCtD
Propafenone—Rash—Doxorubicin—lung cancer	2.37e-05	0.000102	CcSEcCtD
Propafenone—Dermatitis—Doxorubicin—lung cancer	2.36e-05	0.000102	CcSEcCtD
Propafenone—Headache—Doxorubicin—lung cancer	2.35e-05	0.000102	CcSEcCtD
Propafenone—Nausea—Doxorubicin—lung cancer	2.23e-05	9.65e-05	CcSEcCtD
Propafenone—ABCB1—Metabolism—ENO1—lung cancer	8.91e-06	0.000105	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	8.9e-06	0.000105	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—RRM1—lung cancer	8.88e-06	0.000105	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTA3—lung cancer	8.88e-06	0.000105	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTT1—lung cancer	8.88e-06	0.000105	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.88e-06	0.000105	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GNG11—lung cancer	8.87e-06	0.000104	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP2A6—lung cancer	8.86e-06	0.000104	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GCLC—lung cancer	8.86e-06	0.000104	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	8.83e-06	0.000104	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.8e-06	0.000104	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP2A6—lung cancer	8.78e-06	0.000103	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GCLC—lung cancer	8.78e-06	0.000103	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	8.75e-06	0.000103	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL2—lung cancer	8.62e-06	0.000101	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TERT—lung cancer	8.58e-06	0.000101	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALDOA—lung cancer	8.45e-06	9.95e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ENO1—lung cancer	8.4e-06	9.88e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—B4GALT5—lung cancer	8.35e-06	9.83e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—FGFR1—lung cancer	8.34e-06	9.81e-05	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	8.33e-06	9.81e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ENO1—lung cancer	8.32e-06	9.8e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.29e-06	9.76e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HIF1A—lung cancer	8.21e-06	9.66e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NCOA3—lung cancer	8.2e-06	9.66e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	8.19e-06	9.64e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—STK11—lung cancer	8.18e-06	9.62e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTA4—lung cancer	8.13e-06	9.57e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	8.06e-06	9.49e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP2E1—lung cancer	7.99e-06	9.41e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ADCY1—lung cancer	7.98e-06	9.39e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ABCG2—lung cancer	7.98e-06	9.39e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—APOA1—lung cancer	7.92e-06	9.33e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTA2—lung cancer	7.92e-06	9.32e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NQO1—lung cancer	7.9e-06	9.3e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KDR—lung cancer	7.85e-06	9.24e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HPGDS—lung cancer	7.83e-06	9.21e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ENO2—lung cancer	7.83e-06	9.21e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PPP2R1B—lung cancer	7.78e-06	9.15e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.67e-06	9.03e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	7.67e-06	9.03e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTA1—lung cancer	7.64e-06	8.99e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTT1—lung cancer	7.59e-06	8.93e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTP1—lung cancer	7.56e-06	8.9e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ABCC3—lung cancer	7.55e-06	8.89e-05	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	7.53e-06	8.87e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP2E1—lung cancer	7.53e-06	8.86e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP2A6—lung cancer	7.5e-06	8.83e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GCLC—lung cancer	7.5e-06	8.83e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	7.47e-06	8.8e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP2E1—lung cancer	7.46e-06	8.79e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NQO1—lung cancer	7.45e-06	8.77e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NQO1—lung cancer	7.38e-06	8.69e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CAT—lung cancer	7.36e-06	8.67e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.32e-06	8.62e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—AKR1C1—lung cancer	7.32e-06	8.61e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—APC—lung cancer	7.23e-06	8.51e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CG—lung cancer	7.23e-06	8.51e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KIT—lung cancer	7.23e-06	8.51e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—NRAS—lung cancer	7.23e-06	8.51e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.23e-06	8.51e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.16e-06	8.43e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ABCB1—lung cancer	7.16e-06	8.43e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EGF—lung cancer	7.15e-06	8.42e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—STK11—lung cancer	7.12e-06	8.38e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ENO1—lung cancer	7.11e-06	8.37e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—UGT1A1—lung cancer	7.1e-06	8.36e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.09e-06	8.34e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—TYMS—lung cancer	7.03e-06	8.28e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	7e-06	8.23e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTM1—lung cancer	6.95e-06	8.18e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—MAPK3—lung cancer	6.93e-06	8.15e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—POMC—lung cancer	6.88e-06	8.1e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GNG11—lung cancer	6.85e-06	8.06e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—BRAF—lung cancer	6.8e-06	8e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL6R—lung cancer	6.72e-06	7.91e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—STK11—lung cancer	6.71e-06	7.9e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CREBBP—lung cancer	6.71e-06	7.89e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—STK11—lung cancer	6.65e-06	7.83e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTP1—lung cancer	6.59e-06	7.76e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP1A1—lung cancer	6.59e-06	7.76e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—EGFR—lung cancer	6.59e-06	7.76e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ERCC2—lung cancer	6.54e-06	7.69e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALDOA—lung cancer	6.52e-06	7.68e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CAT—lung cancer	6.41e-06	7.55e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAP2K1—lung cancer	6.4e-06	7.53e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP2E1—lung cancer	6.38e-06	7.51e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CD—lung cancer	6.36e-06	7.49e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NCOA3—lung cancer	6.33e-06	7.45e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NQO1—lung cancer	6.31e-06	7.43e-05	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—PIK3CA—lung cancer	6.3e-06	7.41e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.25e-06	7.35e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—KRAS—lung cancer	6.22e-06	7.33e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTP1—lung cancer	6.21e-06	7.31e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.18e-06	7.27e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ABCG2—lung cancer	6.16e-06	7.25e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ADCY1—lung cancer	6.16e-06	7.25e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTP1—lung cancer	6.16e-06	7.25e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—TYMS—lung cancer	6.13e-06	7.21e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.12e-06	7.2e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTM1—lung cancer	6.06e-06	7.13e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CAT—lung cancer	6.04e-06	7.11e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ENO2—lung cancer	6.04e-06	7.11e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HPGDS—lung cancer	6.04e-06	7.11e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PPP2R1B—lung cancer	6e-06	7.06e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CAT—lung cancer	5.99e-06	7.05e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.96e-06	7.01e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ABCB1—lung cancer	5.88e-06	6.92e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTT1—lung cancer	5.86e-06	6.9e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ABCB1—lung cancer	5.83e-06	6.86e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP2A6—lung cancer	5.79e-06	6.82e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GCLC—lung cancer	5.79e-06	6.82e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—TYMS—lung cancer	5.77e-06	6.8e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP1A1—lung cancer	5.74e-06	6.76e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—TYMS—lung cancer	5.72e-06	6.74e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PIK3CA—lung cancer	5.72e-06	6.73e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTM1—lung cancer	5.71e-06	6.72e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MDM2—lung cancer	5.7e-06	6.71e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ERCC2—lung cancer	5.69e-06	6.7e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—STK11—lung cancer	5.69e-06	6.69e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RAF1—lung cancer	5.68e-06	6.68e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTM1—lung cancer	5.66e-06	6.66e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—APOA1—lung cancer	5.65e-06	6.66e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ERBB2—lung cancer	5.62e-06	6.61e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MTOR—lung cancer	5.54e-06	6.52e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CB—lung cancer	5.54e-06	6.52e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ENO1—lung cancer	5.49e-06	6.46e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.41e-06	6.37e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP1A1—lung cancer	5.41e-06	6.37e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ERCC2—lung cancer	5.37e-06	6.32e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP1A1—lung cancer	5.36e-06	6.31e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.34e-06	6.28e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CXCL8—lung cancer	5.33e-06	6.27e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ERCC2—lung cancer	5.32e-06	6.26e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—HRAS—lung cancer	5.29e-06	6.23e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTP1—lung cancer	5.26e-06	6.19e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CG—lung cancer	5.16e-06	6.08e-05	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—AKT1—lung cancer	5.14e-06	6.06e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CAT—lung cancer	5.12e-06	6.03e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CASP3—lung cancer	5.1e-06	6e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.09e-06	5.99e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL2—lung cancer	5.09e-06	5.99e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL6—lung cancer	5.06e-06	5.96e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ABCB1—lung cancer	4.98e-06	5.86e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCND1—lung cancer	4.96e-06	5.84e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—JUN—lung cancer	4.95e-06	5.83e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—APOA1—lung cancer	4.93e-06	5.8e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP2E1—lung cancer	4.92e-06	5.8e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—POMC—lung cancer	4.91e-06	5.78e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—TYMS—lung cancer	4.89e-06	5.76e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NQO1—lung cancer	4.87e-06	5.73e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTM1—lung cancer	4.83e-06	5.69e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MMP9—lung cancer	4.82e-06	5.67e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CDKN1A—lung cancer	4.8e-06	5.65e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PTEN—lung cancer	4.79e-06	5.64e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CREBBP—lung cancer	4.79e-06	5.63e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—AKT1—lung cancer	4.67e-06	5.5e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—APOA1—lung cancer	4.64e-06	5.46e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—APOA1—lung cancer	4.6e-06	5.42e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP1A1—lung cancer	4.58e-06	5.4e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EP300—lung cancer	4.57e-06	5.38e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ERCC2—lung cancer	4.55e-06	5.35e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CD—lung cancer	4.54e-06	5.34e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CG—lung cancer	4.5e-06	5.29e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ALB—lung cancer	4.48e-06	5.27e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SRC—lung cancer	4.44e-06	5.23e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.41e-06	5.19e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—STK11—lung cancer	4.39e-06	5.17e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—VEGFA—lung cancer	4.33e-06	5.09e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—STAT3—lung cancer	4.28e-06	5.04e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—POMC—lung cancer	4.28e-06	5.04e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NRAS—lung cancer	4.27e-06	5.03e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CG—lung cancer	4.24e-06	4.99e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CG—lung cancer	4.2e-06	4.95e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CREBBP—lung cancer	4.17e-06	4.91e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK3—lung cancer	4.09e-06	4.82e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTP1—lung cancer	4.06e-06	4.78e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—POMC—lung cancer	4.03e-06	4.75e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—POMC—lung cancer	4e-06	4.71e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MYC—lung cancer	3.98e-06	4.69e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CB—lung cancer	3.95e-06	4.66e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CD—lung cancer	3.95e-06	4.65e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CAT—lung cancer	3.95e-06	4.65e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—APOA1—lung cancer	3.93e-06	4.63e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CREBBP—lung cancer	3.93e-06	4.63e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTGS2—lung cancer	3.92e-06	4.61e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ALB—lung cancer	3.9e-06	4.59e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CREBBP—lung cancer	3.89e-06	4.59e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EGFR—lung cancer	3.89e-06	4.58e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ABCB1—lung cancer	3.84e-06	4.52e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—TYMS—lung cancer	3.77e-06	4.44e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.77e-06	4.43e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTM1—lung cancer	3.73e-06	4.39e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CD—lung cancer	3.73e-06	4.39e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CD—lung cancer	3.69e-06	4.35e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KRAS—lung cancer	3.68e-06	4.33e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ALB—lung cancer	3.68e-06	4.33e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ALB—lung cancer	3.65e-06	4.29e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CG—lung cancer	3.59e-06	4.23e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP1A1—lung cancer	3.54e-06	4.16e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ERCC2—lung cancer	3.51e-06	4.13e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CB—lung cancer	3.45e-06	4.06e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTEN—lung cancer	3.42e-06	4.02e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—POMC—lung cancer	3.42e-06	4.02e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTGS2—lung cancer	3.41e-06	4.02e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CA—lung cancer	3.38e-06	3.98e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CREBBP—lung cancer	3.33e-06	3.92e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TP53—lung cancer	3.27e-06	3.85e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—EP300—lung cancer	3.26e-06	3.84e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CB—lung cancer	3.25e-06	3.82e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CB—lung cancer	3.22e-06	3.79e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTGS2—lung cancer	3.22e-06	3.79e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTGS2—lung cancer	3.19e-06	3.75e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CD—lung cancer	3.16e-06	3.72e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HRAS—lung cancer	3.13e-06	3.68e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALB—lung cancer	3.12e-06	3.67e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOA1—lung cancer	3.03e-06	3.57e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL6—lung cancer	2.99e-06	3.52e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTEN—lung cancer	2.98e-06	3.51e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—EP300—lung cancer	2.84e-06	3.34e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTEN—lung cancer	2.81e-06	3.3e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTEN—lung cancer	2.78e-06	3.27e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CG—lung cancer	2.77e-06	3.26e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AKT1—lung cancer	2.76e-06	3.25e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CB—lung cancer	2.75e-06	3.24e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTGS2—lung cancer	2.73e-06	3.21e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—EP300—lung cancer	2.68e-06	3.15e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—EP300—lung cancer	2.65e-06	3.12e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—POMC—lung cancer	2.64e-06	3.1e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CREBBP—lung cancer	2.57e-06	3.02e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CD—lung cancer	2.44e-06	2.87e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CA—lung cancer	2.41e-06	2.84e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALB—lung cancer	2.4e-06	2.83e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTEN—lung cancer	2.38e-06	2.8e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—EP300—lung cancer	2.27e-06	2.67e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CB—lung cancer	2.12e-06	2.5e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTGS2—lung cancer	2.1e-06	2.48e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CA—lung cancer	2.1e-06	2.47e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CA—lung cancer	1.98e-06	2.33e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—AKT1—lung cancer	1.97e-06	2.32e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CA—lung cancer	1.96e-06	2.31e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTEN—lung cancer	1.83e-06	2.16e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—EP300—lung cancer	1.75e-06	2.06e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—AKT1—lung cancer	1.72e-06	2.02e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CA—lung cancer	1.68e-06	1.97e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—AKT1—lung cancer	1.62e-06	1.9e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—AKT1—lung cancer	1.6e-06	1.89e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—AKT1—lung cancer	1.37e-06	1.61e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CA—lung cancer	1.29e-06	1.52e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—AKT1—lung cancer	1.06e-06	1.24e-05	CbGpPWpGaD
